BioCentury
ARTICLE | Clinical News

Neugenesis regulatory update

April 15, 2013 7:00 AM UTC

Neugenesis, which develops fungal systems for engineering and production of mammalian proteins, received notice of allowance for a U.S. patent covering its technology to express heteromeric (multi-sub...